NewsBenzingaGuggenheim Maintains Buy on Regeneron Pharmaceuticals, Raises Price Target to $1100 Guggenheim Maintains Buy on Regeneron Pharmaceuticals, Raises Price Target to $1100 Benzinga 2026.11.02 14:21 (GMT+0) Open on Benzinga Other news Jito Names First Outside BAM Node Operators Trump Warns of a ‘1929-Style Economic Depression’ Ahead of the Midterms. The S&P 500 Has Risen After All 19 Midterms Since 1950. Omen AI adds liquid know-how in $16 million Aquatic Labs acquisition US stocks' three major indices rise collectively, Dow up 1.00% intraday Kinross: Back On The Sale Rack (Rating Upgrade) (NYSE:KGC) Is Wall Street Bullish or Bearish on Fortinet Stock?
Trump Warns of a ‘1929-Style Economic Depression’ Ahead of the Midterms. The S&P 500 Has Risen After All 19 Midterms Since 1950.
